Sunday, May 28, 2023
BestWooCommerceThemeBuilttoBoostSales-728x90

CYP1B1 inhibits ferroptosis and induces anti-PD-1 resistance by degrading ACSL4 in colorectal cancer – Cell Death & Disease


  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.

    Article 
    PubMed 

    Google Scholar
     

  • Araghi M, Soerjomataram I, Jenkins M, Brierley J, Morris E, Bray F, et al. Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer. 2019;144:2992–3000.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wang W, Green M, Choi JE, Gijón M, Kennedy PD, Johnson JK, et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569:270–4.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, et al. CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022;40:365.e6–78.e6.

    Article 

    Google Scholar
     

  • Jiang Z, Lim SO, Yan M, Hsu JL, Yao J, Wei Y, et al. TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis. J Clin Investig. 2021;131:e139434.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Liang C, Zhang X, Yang M, Dong X. Recent progress in ferroptosis inducers for cancer therapy. Adv Mater. 2019;31:e1904197.

    Article 
    PubMed 

    Google Scholar
     

  • Song R, Li T, Ye J, Sun F, Hou B, Saeed M, et al. Acidity-activatable dynamic nanoparticles boosting ferroptotic cell death for immunotherapy of cancer. Adv Mater. 2021;33:e2101155.

    Article 
    PubMed 

    Google Scholar
     

  • Li F, Zhu W, Gonzalez FJ. Potential role of CYP1B1 in the development and treatment of metabolic diseases. Pharmacol Ther. 2017;178:18–30.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • D’Uva G, Baci D, Albini A, Noonan DM. Cancer chemoprevention revisited: cytochrome P450 family 1B1 as a target in the tumor and the microenvironment. Cancer Treat Rev. 2018;63:1–18.

    Article 
    PubMed 

    Google Scholar
     

  • Gribben JG, Ryan DP, Boyajian R, Urban RG, Hedley ML, Beach K, et al. Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy. Clin Cancer Res. 2005;11:4430–6.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Maecker B, Sherr DH, Vonderheide RH, von Bergwelt-Baildon MS, Hirano N, Anderson KS, et al. The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells. Blood. 2003;102:3287–94.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13:91–8.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Choudhary D, Jansson I, Stoilov I, Sarfarazi M, Schenkman JB. Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1. Drug Metab Dispos. 2004;32:840–7.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Borin TF, Angara K, Rashid MH, Achyut BR, Arbab AS. Arachidonic acid metabolite as a novel therapeutic target in breast cancer metastasis. Int J Mol Sci. 2017;18:2661.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Garcia V, Gilani A, Shkolnik B, Pandey V, Zhang FF, Dakarapu R, et al. 20-HETE signals through G-protein-coupled receptor GPR75 (G(q)) to affect vascular function and trigger hypertension. Circ Res. 2017;120:1776–88.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhang B, Xu R, Fang G, Zhao Y. 20-HETE downregulates Na/K-ATPase α1 expression via the ubiquitination pathway. Prostaglandins Other Lipid Mediat. 2021;152:106503.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Bao Z, Liu Y, Chen B, Miao Z, Tu Y, Li C, et al. Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury. Nat Commun. 2021;12:4220.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chiorazzi M, Rui L, Yang Y, Ceribelli M, Tishbi N, Maurer CW, et al. Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma. Proc Natl Acad Sci USA. 2013;110:3943–8.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kumarakulasingham M, Rooney PH, Dundas SR, Telfer C, Melvin WT, Curran S, et al. Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis. Clin Cancer Res. 2005;11:3758–65.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Gibson P, Gill JH, Khan PA, Seargent JM, Martin SW, Batman PA, et al. Cytochrome P450 1B1 (CYP1B1) is overexpressed in human colon adenocarcinomas relative to normal colon: implications for drug development. Mol Cancer Ther. 2003;2:527–34.

    CAS 
    PubMed 

    Google Scholar
     

  • Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060–72.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266–82.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Horley NJ, Beresford KJ, Chawla T, McCann GJ, Ruparelia KC, Gatchie L, et al. Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: overcoming cisplatin resistance in CYP1B1-overexpressing lines. Eur J Med Chem. 2017;129:159–74.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Havrylyuk D, Hachey AC, Fenton A, Heidary DK, Glazer EC. Ru(II) photocages enable precise control over enzyme activity with red light. Nat Commun. 2022;13:3636.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chang I, Mitsui Y, Fukuhara S, Gill A, Wong DK, Yamamura S, et al. Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma. Oncotarget. 2015;6:7774–87.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lin Q, Cao J, Du X, Yang K, Yang X, Liang Z, et al. CYP1B1-catalyzed 4-OHE2 promotes the castration resistance of prostate cancer stem cells by estrogen receptor α-mediated IL6 activation. Cell Commun Signal. 2022;20:31.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lei T, Zhang W, He Y, Wei S, Song X, Zhu Y, et al. ZNF276 promotes the malignant phenotype of breast carcinoma by activating the CYP1B1-mediated Wnt/β-catenin pathway. Cell Death Dis. 2022;13:781.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhang T, Zhang G, Chen X, Chen Z, Tan AY, Lin A, et al. Low-dose carbon monoxide suppresses metastatic progression of disseminated cancer cells. Cancer Lett. 2022;546:215831.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zou Y, Li H, Graham ET, Deik AA, Eaton JK, Wang W, et al. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol. 2020;16:302–9.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Huang B, Bao J, Cao YR, Gao HF, Jin Y. Cytochrome P450 1A1 (CYP1A1) catalyzes lipid peroxidation of oleic acid-induced HepG2 cells. Biochemistry. 2018;83:595–602.

    CAS 
    PubMed 

    Google Scholar
     

  • Ghosh MK, Mukhopadhyay M, Chatterjee IB. NADPH-initiated cytochrome P450-dependent free iron-independent microsomal lipid peroxidation: specific prevention by ascorbic acid. Mol Cell Biochem. 1997;166:35–44.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Minoda Y, Kharasch ED. Halothane-dependent lipid peroxidation in human liver microsomes is catalyzed by cytochrome P4502A6 (CYP2A6). Anesthesiology 2001;95:509–14.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Garcia V, Shkolnik B, Milhau L, Falck JR, Schwartzman ML. 20-HETE activates the transcription of angiotensin-converting enzyme via nuclear factor-κB translocation and promoter binding. J Pharm Exp Ther. 2016;356:525–33.

    Article 
    CAS 

    Google Scholar
     

  • Wu W, Warner M, Wang L, He WW, Zhao R, Guan X, et al. Drivers and suppressors of triple-negative breast cancer. Proc Natl Acad Sci USA. 2021;118:e2104162118.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Colombero C, Papademetrio D, Sacca P, Mormandi E, Alvarez E, Nowicki S. Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in androgen-mediated cell viability in prostate cancer cells. Horm Cancer. 2017;8:243–56.

    Article 
    CAS 
    PubMed 

    Google Scholar
     



  • Source link

    Related Articles

    Leave a Reply

    Stay Connected

    9FansLike
    4FollowersFollow
    0SubscribersSubscribe
    - Advertisement -spot_img

    Latest Articles

    %d bloggers like this: